Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 1, 2014
Pharmacy Choice - News - U.S. Pharmaceutical Industry - November 1, 2014

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/31/14 - "Crystalline Form of Tiotropium Bromide" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors MEREU, Andrea; MOROSOLI, Moreno; PENNE', Umberto; PERSEGHINI, Mauro, filed on February 25, 2014, was made available online on October 16, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
10/31/14 - Axxess Pharma to Sponsor NASCAR's Cole Whitt's Race Car in Sprint Cup Series Race [Food and Beverage Close - Up]
Axxess Pharma said, through its subsidiary AllStar Health Brands, that it will sponsor NASCAR driver Cole Whitt's race car in the November 9 NASCAR Sprint Cup Series Race. For Axxess Pharma, this is the latest promotional venture the company has taken with Nutritional Products International, a Global Sales and Communication firm. "This is a major
10/31/14 - Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders
Cellceutix Corporation, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antibiotic applications, is pleased to provide a strategic and operations update to shareholders from the Company's newly appointed Chief Operating Officer, Dr. Cellceutix disclosed in an 8- K filing with the U.S....
10/31/14 - DARA BioSciences Continues to Support Patient Outreach and Education in Conjunction With Breast Cancer Awareness Month
DARA BioSciences, Inc., an oncology supportive care specialty pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatments, announced its continued support of patient education and outreach to..
10/31/14 - Determination That TOPICORT (Desoximetasone) Cream and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements. The 1984 amendments include what is now section 505 of
10/31/14 - Edwards Highlights Benefits of Dry Vacuum Solutions for Pharmaceutical Market [Global Data Point]
Industry expert from Edwards, Jeff Luby, will be presenting a paper at the conference on Monday November 3rd at 1 pm, "Intelligent Vacuum Pumping Solutions for the Pharmaceutical Market." We are delighted to be highlighting our range of dry vacuum capabilities for the pharmaceutical industry at Pharma Expo ", said Jeff Luby, US Applications Manager
10/31/14 - FDA Approves Protein Sciences Flu Vaccine For Older Americans [The Hartford Courant]
Oct. 31 The Food and Drug Administration has extended its approval of the flu vaccine made by Meriden's Protein Sciences to adults age 50 and older. Making the drug available to older people is important for public health, said Protein Sciences Chief Medical Officer Dr. Protein Sciences makes its vaccines using a modern cell culture technology, w
10/31/14 - Flamel Technologies Announces Third Quarter Results of Fiscal Year 2014
Flamel Technologies today announced its financial results for the third quarter of fiscal year 2014. Highlights from the quarter include:. Flamel is now the only drug manufacturer offering FDA- approved versions of all three product presentations of phenylephrine hydrochloride injection. Flamel announced data from a First-in-Man clinical study of i
10/31/14 - Gynesonics Secures FDA Approval for a Pivotal IDE Clinical Trial for Vizablate System [Professional Services Close - Up]
Gynesonics reported it has received approval from the U.S. Food and Drug Administration of an investigational device exemption for the pivotal trial, Sonography Guided Transcervical Ablation of Uterine Fibroids, of its newly-designed VizAblate System. "We are pleased to have FDA approval to begin this pivotal trial thus validating the pre-clinical
10/31/14 - Horizon Pharma plc Announces DUEXIS(R) Selected as Winner of Chicago Innovation Award
Last night at Chicago's Harris Theater, Timothy P. Walbert, chairman, president and chief executive officer of Horizon Pharma, received the award with nearly 1,500 business and civic leaders in attendance. "With a large percentage of the approximately 50 million individuals suffering from arthritis in the United States taking prescription-strength
10/31/14 - Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Ampligen(R)
{nfg} Immunomedics, Inc., announced isactuzumab govitecan, the Company's proprietary solid-tumor antibody-drug conjugate, continues to produce encouraging results in a Phase 2 clinical trial in heavily-pretreated patients with diverse, metastatic solid cancers. David M. Goldenberg, Chairman, Chief Scientific Officer, and Chief Medical Officer, at t
10/31/14 - Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences
Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced that it will report third quarter 2014 financial results before the NASDAQ Market opens on Friday, November 7, 2014.
10/31/14 - Iraq Joins USP Global Program to Assist with Medicine Quality Testing
Release date- 30102014- Rockville, Md.,- The National Center for Drug Control and Research of Iraq is the newest participant in a U.S. Pharmacopeial Convention program designed to assist developing countries improve medicine quality. 'Joining USP's Technical Assistance Program is an important step for increasing Iraq's capacity to ensure the safety
10/31/14 - La Jolla Pharmaceutical Updates on Data Presentation at the American Society of Nephrology Kidney Week Event [Professional Services Close - Up]
La Jolla Pharmaceutical Company reported that an abstract of the results for the Company's Phase 2 clinical trial of GCS-100 in chronic kidney disease has been selected by the American Society of Nephrology's Program Committee for poster presentation at the Kidney Week Annual Meeting. "We are delighted that results from our Phase 2 study of GCS-10
10/31/14 - Medigene's Licensee enters promotion agreement to expand Veregen? product sales in the United States [EMBIN (Emerging Markets Business Information News]
Martinsried/ Munich October 30 2014. Medigene AG announces that its US licensee Fougera Pharmaceuticals Inc a Sandoz company has signed a promotion agreement with Women's Choice Pharmaceuticals LLC a specialty pharmaceutical company based in Gilbert Arizona for Veregen ? ointment a treatment for external genital warts. Frank Mathias Chief...
10/31/14 - Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy
Medivation Inc. and Astellas today announced plans to initiate a global Phase 3 clinical trial that will evaluate the efficacy and safety of enzalutamide in patients with high-risk, hormone-sensitive, non-metastatic prostate cancer that has biochemically recurred following definitive local therapy with radical prostatectomy and/or radiation...
10/31/14 - New Market Report: Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
New Pharmaceuticals market report from Global Markets Direct: " Kyorin Pharmaceutical Co., Ltd.- Product Pipeline Review- 2014" Boston, MA 10/31/2014 Global Markets Direct's,' Kyorin Pharmaceutical Co., Ltd.- Product Pipeline Review- 2014', provides an overview of the Kyorin Pharmaceutical Co., Ltd.' s pharmaceutical research and development
10/31/14 - New Toxicology and Pharmacology Study Findings Have Been Reported by Investigators at MHRA (Recommendations from a global cross-company data sharing...
New Toxicology and Pharmacology Study Findings Have Been Reported by Investigators at MHRA. By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies are discussed in a new report. According to news reporting from London, United Kingdom, by NewsRx journalists, research stated, "An international expert group which
10/31/14 - Nielsen Catalina Solutions and Crossix Deliver Breakthrough Television Solution for Pharma
By a News Reporter-Staff News Editor at Entertainment Newsweekly Nielsen Catalina Solutions, a leader in behavior-based TV planning and analytics, and Crossix Solutions, the leader in healthcare marketing analytics, have announced a new collaboration that will enable pharma advertisers and their media agencies to improve how they plan and optimiz
10/31/14 - OptiNose Announces Publication of Pivotal Phase III Results for Investigational Migraine Treatment Developed by OptiNose Using Bi-Directional? Breath Powered? Technology
OptiNose today announced that the TARGET study a pivotal phase III study evaluating the ef?cacy and safety of AVP-825, will be published in the January 2015 issue of Headache, The Journal of Head and Face Pain, the official journal of the American Headache Society. A New Drug Application for AVP-825 has been accepted by the FDA, and the Prescr
10/31/14 - Patent Issued for Natural Product Derivatives with Antiprotozoal Activity
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventor Zhu, Shuren, filed on October 5, 2012, was published online on October 14, 2014. The patent's assignee for patent number 8859578 is Radix Pharmaceuticals, Inc.. It is one of the most common infectious diseases in at
10/31/14 - Patent Issued for Pharmaceutical Formulations of Modafinil
By a News Reporter-Staff News Editor at Health& Medicine Week Cephalon, Inc. has been issued patent number 8859621, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R.. This patent was filed on August 21, 2012 and was published onli
10/31/14 - Paulsen Statement on FDA Approval of Meningitis B Vaccine
Congressman Erik Paulsen released the following statement after the Food and Drug Administration's announcement that they are granting approval of Trumenba, the first vaccine licensed in the U.S. to prevent contraction of Meningitis B. "While this news is certainly welcome, the question still remains why Americans must wait longer than others in E
10/31/14 - Purdue Pharma, P.F. Laboratories, Purdue Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Oct. 31 Purdue Pharma, Stamford, Connecticut, P.F. Laboratories, Totowa, New Jersey, and Purdue Pharmaceuticals, Wilson, North Carolina, have been assigned a patent developed by Curtis Wright, Rockport, Massachusetts, Benjamin Oshlack, Boca Raton, Florida, and Christopher Breder, Bethesda, Maryland, for "pharmaceutical formulatio
10/31/14 - Seattle Genetics Reports Third Quarter 2014 Financial Results [Global Data Point]
"Our financial strength and clinical development progress in the third quarter were marked by record ADCETRIS net sales, up 32 percent from the third quarter of 2013, and positive topline results from the AETHERA phase 3 clinical trial," said Clay B. Siegall, Ph.D., President and Chief Executive Officer at Seattle Genetics. ?Reported positive top
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415